Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene

Diabetes. 1994 May;43(5):690-5. doi: 10.2337/diab.43.5.690.

Abstract

In search of genetic determinants of susceptibility to diabetic nephropathy, we examined the association between DNA sequence differences at the locus of angiotensin I-converting enzyme (ACE) and renal complications in 151 insulin-dependent diabetes mellitus (IDDM) patients with a diabetes duration of 16-21 years. This nested case-control study included 77 normoalbuminuric control subjects (albumin excretion rate < 30 micrograms/min) and 74 cases with evidence of nephropathy ranging from microalbuminuria to overt proteinuria. DNA from each of these patients was genotyped at the ACE locus by a three-allele restriction fragment-melting polymorphism (RFMP) (Dde I), which we described recently, and a two-allele insertion/deletion recognized as an Xba I restriction fragment-length polymorphism, which has been shown by other investigators to be associated with serum levels of ACE and with risk of myocardial infarction. The least common allele of the Dde I RFMP was significantly more frequent among cases with nephropathy than among normoalbuminuric control subjects (12.8 vs. 4.5%, P < 0.05). The deletion in the ACE gene was also more frequent in case than in control subjects (56.1 vs. 47.4%), but the difference was not statistically significant (P < 0.25) with this sample size. To determine the independence of these associations, the two polymorphisms were analyzed jointly to identify Xba I/Dde I haplotypes. As might be expected, carriers of the Xba I/Dde I '+ =' haplotype had a fourfold risk of developing diabetic nephropathy (odds ratio [OR] 4.0, 95% confidence interval [CI] 1.5-11.0). However, this did not explain all of the excess Xba I '+' allele among cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Age of Onset
  • Albuminuria
  • Blood Glucose / metabolism
  • DNA / analysis
  • Deoxyribonucleases, Type II Site-Specific
  • Diabetes Mellitus, Type 1 / enzymology
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetes Mellitus, Type 1 / physiopathology
  • Diabetic Nephropathies / enzymology
  • Diabetic Nephropathies / genetics*
  • Diabetic Nephropathies / physiopathology
  • Exons
  • Follow-Up Studies
  • Genetic Carrier Screening
  • Genetic Predisposition to Disease
  • Genotype
  • Haplotypes / genetics
  • Humans
  • Hyperglycemia / epidemiology
  • Hypertension / diagnosis
  • Hypertension / genetics
  • Hypertension / physiopathology
  • Kidney Function Tests
  • Odds Ratio
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Restriction Fragment Length*
  • Reference Values
  • Time Factors

Substances

  • Blood Glucose
  • DNA
  • endodeoxyribonuclease DdeI
  • endodeoxyribonuclease XBAI
  • Deoxyribonucleases, Type II Site-Specific
  • Peptidyl-Dipeptidase A